COLL - Collegium Pharmaceutical Inc logo

COLL

Collegium Pharmaceutical Inc

Collegium Pharmaceutical develops and commercializes medications for pain management, including extended-release opioids and a CNS stimulant for ADHD. Their products aim to address severe and persistent pain while minimizing abuse risks through innovative delivery methods.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$2,663today

Score Overview

1 Year
Score
Net Growth-23.79%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth3.54%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.5
Net Growth-33.00%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth191.91%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth150.88%
Net Trend70%
Net Income Consistency
Rev Growth472x
Rev Trend90%
Revenue Consistency
All Time
Scoreโ€”
Net Growth275.80%
Net Trend64%
Net Income Consistency
Rev Growthโ€”
Rev Trend91%
Revenue Consistency

See the full market ranking โ†’

Collegium Pharmaceutical Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 310M to $ 780M and net income grew from $ 26M to $ 62M. Revenue increased in every one of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 0.00 to $ 780M and net income went from -$ 27M to $ 62M. Revenue increased in 9 of those 10 years; net income in 7.

Collegium Pharmaceutical Inc currently holds a 5-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 28.15โ€”
1 Year2025-08-13
$ 37.86-25.65%
5 Years2021-08-13
$ 17.7558.59%
10 Years2016-08-12
$ 10.57166.32%
All Time2015-05-07
$ 12.29129.05%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 808M$ 47M$ 129M
2025$ 780M$ 62M$ 406M
2024$ 631M$ 69M$ 162M
2023$ 566M$ 48M$ 310M
2022$ 463M-$ 25M$ 173M
2021$ 276M$ 71M$ 186M
2020$ 310M$ 26M$ 174M
2019$ 296M-$ 22M$ 170M
2018$ 280M-$ 39M$ 146M
2017$ 28M-$ 74M$ 118M
2016$ 1M-$ 94M$ 153M
IPO2015$ 0.00-$ 27M$ 95M

Explore beyond COLL

You're looking at Collegium Pharmaceutical Inc. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies